Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Regorafenib”

292 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 292 results

Early research (Phase 1)Study completedNCT01853046
What this trial is testing

Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment

Who this might be right for
Neoplasms
Bayer 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078305
What this trial is testing

Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 134
Testing effectiveness (Phase 2)Ended earlyNCT03563157
What this trial is testing

QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine

Who this might be right for
Colorectal Cancer MetastaticmCRC
ImmunityBio, Inc. 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05622136
What this trial is testing

Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Liver CancerHepatocellular Carcinoma
Instituto do Cancer do Estado de São Paulo 28
Not applicableStudy completedNCT03698253
What this trial is testing

Metastatic Colorectal Cancer Treated With Regorafenib and FOLFIRI

Who this might be right for
Colorectal Cancer
Kaohsiung Medical University Chung-Ho Memorial Hospital 41
Early research (Phase 1)Study completedNCT03215264
What this trial is testing

To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05608044
What this trial is testing

Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Agenus Inc. 234
Testing effectiveness (Phase 2)Ended earlyNCT06006923
What this trial is testing

Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer

Who this might be right for
MSI-H Colorectal Cancer
Anwaar Saeed 1
Post-approval studies (Phase 4)Ended earlyNCT02287025
What this trial is testing

Regorafenib in Metastatic Colorectal Cancer - Does Educating Physicians Change Patient Outcomes?

Who this might be right for
Physician Education
Bayer 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT05194293
What this trial is testing

Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer

Who this might be right for
Stage IB Hepatocellular Carcinoma AJCC v8Stage II Hepatocellular Carcinoma AJCC v8Stage III Hepatocellular Carcinoma AJCC v8+1 more
Academic and Community Cancer Research United 4
Early research (Phase 1)Study completedNCT01117623
What this trial is testing

Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies

Who this might be right for
Neoplasm
Bayer 86
Not applicableUnknownNCT05024539
What this trial is testing

Real-World Effectiveness of Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shujun Yang 300
Testing effectiveness (Phase 2)Looking for participantsNCT05917431
What this trial is testing

Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC

Who this might be right for
Unresectable Hepatocellular CarcinomaOligometastatic Disease
Peking University Cancer Hospital & Institute 39
Not applicableStudy completedNCT04343456
What this trial is testing

Salvage Surgery for Patients With Metastatic GIST With Rego

Who this might be right for
Gastrointestinal Stromal TumorsMetastasisDisease Progression
Chang Gung Memorial Hospital 41
Testing effectiveness (Phase 2)WithdrawnNCT07137390
What this trial is testing

A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Temporarily pausedNCT06454409
What this trial is testing

Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic Syndrome/Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic Syndrome+2 more
City of Hope Medical Center 20
Early research (Phase 1)Study completedNCT01002378
What this trial is testing

The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of Regorafenib

Who this might be right for
Dietary FatsPharmacokinetics
Bayer 24
Testing effectiveness (Phase 2)Looking for participantsNCT06949982
What this trial is testing

Efficacy And Safety Of Hydroxychloroquine Combined With Methotrexate, Capecitabine And Bevacizumab Vs. Regorafenib In Participants With Refractory Metastatic Colorectal Cancer With Mutations In RAS Genes

Who this might be right for
Metastatic Colorectal Cancer (mCRC)Colorectal Neoplasms
Sergey Orlov, MD 60
Large-scale testing (Phase 3)UnknownNCT01189903
What this trial is testing

Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer Patients

Who this might be right for
Asian Colorectal Cancer Patients
National University Hospital, Singapore
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07514429
What this trial is testing

Regorafenib After Failure of Lenvatinib in Patients With Unresectable HCC: The RELEVANT-HCC Trial

Who this might be right for
Carcinoma, HepatocellularLenvatinibTreatment Failure
Ju Hyun Shim 24
Next Page